[Combined use of tumor markers and MRI tomography in differential diagnosis of ovarian neoplasms].
15 women with indeterminate diagnosis of ovarian lesion have undergone a standard examination, NMR tomography and enzyme immunoassay for tumor markers (KA-125, KA-19-9, CEA). NMR-tomography appeared highly informative in differentiating benign and malignant tumors of the ovaries, effective in staging. The oncomarkers are effective in screening for cancer risk groups, control of treatment efficacy and the disease prognosis. Carbohydrate (tumor-associated) antigen KA-125 is most specific for ovarian cancer. Combined use of the tumor markers and NMR-tomography provides a reliable diagnosis.
Pavlov
S B
SB
Akulina
E A
EA
Pavlova
G B
GB
D000230:Adenocarcinoma / Q000097:blood / Q000175:diagnosis*; D014408:Biomarkers, Tumor / Q000097:blood; D018394:CA-125 Antigen / Q000097:blood*; D018395:CA-19-9 Antigen / Q000097:blood*; D002272:Carcinoembryonic Antigen / Q000097:blood*; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D007124:Immunoenzyme Techniques; D008279:Magnetic Resonance Imaging; D010051:Ovarian Neoplasms / Q000097:blood / Q000175:diagnosis*; D012680:Sensitivity and Specificity
D014408:Biomarkers, Tumor; D018394:CA-125 Antigen; D018395:CA-19-9 Antigen; D002272:Carcinoembryonic Antigen